The role of orexigenic and anorexigenic factors in an interdisciplinary weight loss therapy for obese adolescents with symptoms of eating disorders

International Journal of Clinical Practice

Volumn 64, Issue 6, 2010, Pages 784-790

  Carnier, J ^a,c   De Piano, A ^a   De Lima Sanches, P ^a   Tock, L ^a   Do Nascimento, C M O ^a   Oyama, L M ^a   Correa F A ^a   Ernandes, R H ^b   Lederman, H ^a   De Mello, M T ^a   Tufik, S ^a   Damaso A R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Association Found of Incentive to Psychobiology   (Brazil)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; GHRELIN; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BINGE EATING DISORDER; BODY COMPOSITION; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE COURSE; DOWN REGULATION; EATING DISORDER; ENERGY BALANCE; FEMALE; HUMAN; INCREASED APPETITE; INTERDISCIPLINARY EDUCATION; INTRAABDOMINAL FAT; LONG TERM CARE; MALE; OBESITY; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; SHORT COURSE THERAPY; SUBCUTANEOUS FAT; SYMPTOM; TREATMENT DURATION; UPREGULATION; WEIGHT CONTROL; WEIGHT REDUCTION;

ADOLESCENT; BINGE-EATING DISORDER; BODY MASS INDEX; BULIMIA NERVOSA; ENERGY INTAKE; FEMALE; GHRELIN; HUMANS; HYPOTHALAMIC HORMONES; MALE; MELANINS; NEUROPEPTIDE Y; OBESITY; PATIENT CARE TEAM; PHYSICAL THERAPY MODALITIES; PITUITARY HORMONES; WEIGHT LOSS;

EID: 77950683585     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02306.x     Document Type: Article

References (44)

1. World Health Organization. Obesity: preventing and Managing the Global Epidemic. WHO Obesity Technical Report Series 894; Geneva 2000 World Health Organization.
2. Mokadad AH, Serdula MK, Dietz WH et al. The continuing epidemic of obesity in the United States. JAMA 2000 284 : 1650 1651.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.
4. Dowell P, Hu Z, Lane MD. Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annu Rev Biochem 2005 74 : 515 534.
5. Hellstrom PM, Geliebter A, Naslund E et al. Peripheral and central signals in control of eating in normal, obese and binge eating subjects. Br J Nutr 2003 92 : 547 557.
6. Arora S, Anubhuti. Role of neuropeptides in appetite regulation and obesity: a review. Neuropeptides 2006 40 : 375 401.
7. Considine RV, Sinha K, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996 334 : 292 295.
8. Tanner JM, Whithouse RH. Clinical Longitudinal standards for height, weight, weight velocity and stages of puberty. Arch Dis Child 1976 51 : 170 179.
9. Fields DA, Hunter GR, Goran MI. Validation of the BOD POD with hydrostatic weighing: influence of body clothing. Int J Obes 2000 24 : 200 205.
10. Ma G, Yao M, Liu Y et al. Validation of a new pediatric air-displacement plethysmograph for assessing body composition in infants. Am J Clin Nutr 2004 79 : 653 660.
11. Ribeiro-Filho FF, Faria NA, Ajzen S et al. Methods of estimation of visceral fat: advantages of ultrassonography. Obes Res 2003 11 : 1488 1494.
12. Matthews DR, Hosker JP, Rudenski AS et al. Homeostais model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 419.
13. Gormally J, Black S, Daston S et al. The assessment of binge eating severity among obese persons. Addict Behav 1982 7 : 47 55.
14. Henderson M, Freeman CPL. A self-rating scale for bulimia. The BITE. Br J Psychiatr 1987 50 : 18 24.
15. Dâmaso A, de Piano A, Tock L et al. Nutritional and clinical Strategies on Prevention and Treatment of NAFLD and Metabolic Syndrome. In : Preedy VR, Srirajaskanthan R, Lakshman R et al., eds. Nutrition, Diet Therapy and the Liver: Nutritional and Clinical Strategies on the Prevention and Treatment of NAFLD and Metabolic Syndrome.
16. Freitas S, Lopes CS, Coutinho W et al. Tradução e adaptação para o português da Escala de Compulsão Alimentar Periódica. Rev Brás Psiquiatr 2001 23 : 215 220.
17. Cordás TA, Hochgraf PB. O "BITE" Instrumento para avaliação da Bulimia nervosa: Versão para o português. J Bras Psiquiatr 1993 42 : 141 144.
18. Isnard P, Michel G, Frelut ML et al. Binge eating and psychopathology in severely obese adolescents. Int J Eat Disord 2003 34 : 235 243.
19. National Research Council, Food and Nutrition Board. Recommended Dietary Allowances. 10th ed.
20. Foschini D, Araújo RC, Bacurau RFP et al. Treatment of obese adolescents: the influence of periodization models and ace genotype. Obesity 2009. doi:.
21. Donnelly JE, Blair SN, Jakicic JM et al. ACSM: position stand on the appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009 41 : 459 471.
22. Lofrano-Prado MC, Antunes HKM, do Prado WL et al. Quality of life in Brazilian obese adolescents: effects of a long-term multidisciplinary lifestyle therapy. Health Qual Life Outcomes 2009 7 : 61.
23. Caranti DA, Lazzer S, Dâmaso AR et al. Prevalence and risk factors of metabolic syndrome in Brazilian and Italian obese adolescents: a comparison study. Int J Clin Pract 2008 62 : 1526 1532.
24. de Piano A, Prado WL, Caranti DA et al. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2007 44 : 446 452.
25. Baltatzi M, Hatzitolios A, Tziomalos K et al. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract 2008 62 : 1432 1440.
26. Han JH, Park HS, Shin CI et al. Metabolic syndrome and quality of life (QOL) using generalised and obesity-specific QOL scales. Int J Clin Pract 2009 63 : 735 741.
27. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspective on fat. Acta Physiol Scand 2005 184 : 285 293.
28. Freemantle N, Holmes J, Hockey A, Kumar S. How strong is the association between abdominal obesity and the incidence of type 2 diabetes? Int J Clin Pract 2008 62 : 1391 1396.
29. Caranti DA, de Mello MT, Prado WL et al. Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents. Metabolism 2007 56 : 1293 1300.
30. Goldberg Y, Boaz M, Matas Z et al. Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects. Clin Nutr 2009 28 : 21 5.
31. Dâmaso AR, do Prado WL, de Piano A et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis 2008 40 : 132 139.
32. Kuo LE, Kitlinska JB, Tilan JU et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007 13 : 803 811.
33. Hung YJ, Chu NF, Wang SC et al. Correlation of plasma leptin and adiponectin with insulin sensitivity and beta-cell function in children - the Taipei Children Heart Study. Int J Clin Pract 2006 60 : 1582 1587.
34. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995 269 : 543 546.
35. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004 59 : 305 331.
36. Muzumdar R, Ma X, Yang X et al. Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. FASEB J 2003 17 : 1130 1132.
37. Reinehr T, de Sousa G, Roth CL. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol (Oxf) 2008 68 : 304 310.
38. Williams G, Cai XJ, Elliot JC et al. Anabolic neuropeptides. Physiol Behav 2004 81 : 211 222.
39. Gorol K, Akio I. Melanin-concentrating hormone as a metabolic and cognitive regulatory factor. Curr Med Chem 2003 3 : 217 227.
40. Xu R, Li S, Paruchova J et al. Bicyclic heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists. Bioorg Med Chem 2006 14 : 3285 3299.
41. McBriar MD, Guzik H, Shapiro S et al. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo hexyl ureas. J Med Chem 2006 49 : 2294 2310.
42. Kowalski TJ, Spar BD, Weig B et al. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Eur J Pharmacol 2006 535 : 182 191.
43. Austin SB, Kim J, Wiecha J et al. School-based overweght preventive intervention lowers incidence of disordered weight-control behaviors in early adolescent girls. Arch Pediatr Adolesc Med 2007 161 : 865 869.
44. Carnier J, Lofrano MC, Prado WL et al. Hormonal alteration in obese adolescents with eating disorder: effects of multidisciplinary therapy. Horm Res 2008 70 : 79 84.